June 21, 2021

Who's Most Likely to Join a Clinical Trial?

Cancer patients most likely to sign up for clinical trials during their treatment include people of color, those with higher incomes and those who are younger, a new study finds. “This study informs our understanding of who is participating in cancer clinical trials,” said study author Dr. Lincoln Sheets, an assistant research professor at the...

Stigma Worsens Sickle Cell Disease Outcomes

Sickle cell disease (SCD) is an inherited hemoglobinopathy that causes decreased life expectancy and acute and chronic pain. As a disease that predominately affects Black patients, SCD is also strongly tied to racism and health inequities. Analyzing the various ways that stigma affects Black patients could vastly improve SCD outcomes. This systematic review identified four...

Racism, Poor Mental Health, and Sickle Cell Disease

While there is a significant body of research supporting the connection between racism in healthcare and poor psychological and physiological health outcomes, the literature in pediatric care is lacking, especially with regard to sickle cell disease (SCD). As SCD predominately affects Black individuals, many patients—including many children—experience forms of racism in healthcare, including denial of...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.